Existing EU and USA Approvals for Registration in Central and East
Europe, Russia and the CIS:
Companies wishing to register and market their products, whether
pharmaceuticals or medical devices which already have regulatory
approvals outside of these geographical regions frequently need
guidance on how to proceed in these countries.
Before making strategic decisions and potentially significant financial
decisions regarding market entry it is more cost effective to have
MMA review the proposition and advise on both time lines to be expected
and likely costs to be encountered.
MMA will conduct such reviews promptly and report comprehensively.
For companies wishing to move forward following such a review MMA
is able to manage the regulatory process locally.
|